Q1 2026 · 13F-HR
TANG CAPITAL MANAGEMENT LLCholdings as filed
Filed 2026-05-15 · accession 0001214659-26-006493
$1.97B
Reported value
51
Positions
2026-03-31
Period end
The Brief · TANG CAPITAL MANAGEMENT LLC · Q1 2026
AI · grounded in 13F
TANG CAPITAL MANAGEMENT LLC closed its position in RNAGBP for a reduction of $64.9M. The fund also exited positions in VRTX and TVTX, totaling losses of $36.3M and $26.7M respectively. On the buy side, the fund established a new position in CMPS worth $22.1M and increased its holdings in CORT by 856.85%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $181.2M | 9.20% | 12,229,500 | Common | SHARED |
| 15102K100 | CELC | CELCUITY INC | $119.8M | 6.09% | 1,050,000 | Common | SHARED |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $114.2M | 5.80% | 1,236,027 | Common | SHARED |
| 36315X101 | LKFT | GALAPAGOS NV | $113.6M | 5.77% | 3,785,991 | Common | SHARED |
| 78462F103 | SPY | STATE STR SPDR S&P 500 ETF T | $109.3M | 5.55% | 168,000 | Common | SHARED |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $108.8M | 5.53% | 2,259,889 | Common | SHARED |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $103.4M | 5.25% | 3,399,900 | Common | SHARED |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $102.2M | 5.19% | 1,500,000 | Common | SHARED |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $95.4M | 4.85% | 1,892,200 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $92.1M | 4.68% | 4,573,530 | Common | SHARED |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $88.8M | 4.51% | 16,790,809 | Common | SHARED |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $83.4M | 4.23% | 1,188,624 | Common | SHARED |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $79.9M | 4.06% | 2,649,368 | Common | SHARED |
| 032724106 | ANAB | ANAPTYSBIO INC | $73.8M | 3.75% | 1,330,879 | Common | SHARED |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $60.5M | 3.07% | 1,500,000 | Common | SHARED |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $54.4M | 2.76% | 707,500 | Common | SHARED |
| 457669307 | INSM | INSMED INC | $42.5M | 2.16% | 260,000 | Common | SHARED |
| 09075V102 | BNTX | BIONTECH SE | $41.8M | 2.12% | 470,000 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $35.1M | 1.78% | 1,792,626 | Common | SHARED |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $25.9M | 1.32% | 4,814,700 | Common | SHARED |
| 74017N105 | PGEN | PRECIGEN INC | $24.8M | 1.26% | 6,417,500 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $22.2M | 1.13% | 264,692 | Common | SHARED |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $22.1M | 1.12% | 4,002,200 | Common | SHARED |
| G2545C104 | CBIO | CRESCENT BIOPHARMA INC. | $21.3M | 1.08% | 1,160,000 | Common | SHARED |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $16.3M | 0.83% | 500,000 | Common | SHARED |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $16.3M | 0.83% | 500,000 | Common | SHARED |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $15.0M | 0.76% | 450,000 | Common | SHARED |
| 67080N101 | NUVB | NUVATION BIO INC | $13.5M | 0.69% | 3,149,557 | Common | SHARED |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $7.7M | 0.39% | 6,143,132 | Common | SHARED |
| 48115J109 | DERM | JOURNEY MED CORP | $7.6M | 0.38% | 1,610,000 | Common | SHARED |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $7.0M | 0.35% | 500,000 | Common | SHARED |
| 09062X103 | BIIB | BIOGEN INC | $6.4M | 0.33% | 35,000 | Common | SHARED |
| M96088105 | URGN | UROGEN PHARMA LTD | $6.3M | 0.32% | 350,000 | Common | SHARED |
| 04335A105 | ARVN | ARVINAS INC | $5.7M | 0.29% | 538,658 | Common | SHARED |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $5.3M | 0.27% | 4,245,085 | Common | SHARED |
| 60770K107 | MRNA | MODERNA INC | $5.1M | 0.26% | 100,000 | Common | SHARED |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $5.0M | 0.25% | 6,250,000 | Common | SHARED |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $4.9M | 0.25% | 664,314 | Common | SHARED |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $4.3M | 0.22% | 600,000 | Common | SHARED |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $4.1M | 0.21% | 451,114 | Common | SHARED |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $3.4M | 0.17% | 100,000 | Common | SHARED |
| 29479A108 | ERAS | ERASCA INC | $3.2M | 0.16% | 200,000 | Common | SHARED |
| 19249H103 | CHRS | COHERUS ONCOLOGY INC | $3.2M | 0.16% | 1,886,748 | Common | SHARED |
| 65487U108 | NKTX | NKARTA INC | $3.1M | 0.16% | 1,480,823 | Common | SHARED |
| 02155H200 | ALT | ALTIMMUNE INC | $2.1M | 0.10% | 666,022 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $2.0M | 0.10% | 483,021 | Common | SHARED |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $1.8M | 0.09% | 400,000 | Common | SHARED |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $1.4M | 0.07% | 1,167,773 | Common | SHARED |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $857,762 | 0.04% | 439,878 | Common | SHARED |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $623,532 | 0.03% | 399,700 | Common | SHARED |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $358,000 | 0.02% | 100,000 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.